Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2843889 | 0.90 | POLB (0.37) | ADRB3ADRA2BADRA2CALDH1A1 | |
| SCHEMBL6760115 | 0.90 | POLB (0.37) | ADRB3ADRA2BADRA2CALDH1A1 | |
| SCHEMBL8238400 | 0.90 | POLB (0.37) | ADRB3ADRA2BADRA2CALDH1A1 | |
| SCHEMBL2843887 | 0.90 | POLB (0.37) | ADRB3ADRA2BADRA2CALDH1A1 | |
| SCHEMBL14020643 | 0.88 | POLB (0.38) | ADRB3ADRA2BADRA2CALDH1A1 | |
| SCHEMBL6760157 | 0.83 | CTSB (0.31) | CTSB | |
| SCHEMBL2837626 | 0.83 | CTSB (0.31) | CTSB | |
| SCHEMBL2837629 | 0.83 | CTSB (0.31) | CTSB | |
| SCHEMBL8245129 | 0.83 | CTSB (0.31) | CTSB | |
| SCHEMBL14020644 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007014918-A1 | MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2007-02-08 | — | — | WO | disclosed |